Abstract: An optical sensor device (1) for a fluid substance (LS) comprises a device body (2) having a detection portion (14), associated to which is a sensitive optical part that comprises at least one of an emitter (20) and a receiver (21) of an optical radiation (Re, Rr). The detection portion (14) is made of a material transparent to the optical radiation (Re, Rr) and has an inner surface (23a, 23b) and an outer surface (15), the outer surface (15) being designed to be in contact with the fluid substance (LS) and the inner surface (23a, 23b) being designed to be isolated from the fluid substance. The at least one of the emitter (20) and the receiver (21) of the sensitive optical part is optically coupled to the inner surface (23a, 23b) of the detection portion (14), in such a way that the optical radiation (Re, Rr) is at least in part propagated through the detection portion (14), in particular with an angle and/or an intensity that is variable as a function of a characteristic of the fluid substance.

Abstract: The present invention relates to a visualized virtual agent configured to provide a visual response to a user, wherein the visualized virtual agent is further configured to provide an artificial physiological color change response to a user on the basis of one or more user-specific parameter, wherein the visualized virtual agent is configured to acquire user-specific data for at least one user-specific parameter using at least one sensor, the one or more user-specific parameter comprising activity data of the user and/or physio-psychological data of the user, and wherein the artificial physiological color change response is provided in response to monitored changes of the acquired user-specific data for the at least one user-specific parameter of the activity data of the user and/or the physio-psychological data of the user, the artificial physiological color change response comprising at least in part a color change of the visualized virtual agent.

Abstract: The present invention relates to a system for providing a team of at least two virtual agents, the system comprising at least one central processing unit, at least one non-transitory computer readable storage medium, at least one input device, and at least one output device, wherein the virtual agents are distinctively presented to a user by the at least one output device and each of the at least two virtual agents is assigned to a different field of interest and each of the at least two virtual agents is configured to provide visual and/or audio recommendations of the field of interest assigned to the respective virtual agent to the user on the basis of user-specific data and on the basis of the current state of the user, wherein at least two virtual agents of the team assigned to at least two different fields of interest provide recommendations to the user in the current state so that the user is provided with bidirectional, multidirectional, or even contradictory recommendations of at least two different f

Abstract: The present invention relates to a visualized virtual agent configured to provide a visual response to a user, wherein the visualized virtual agent is further configured to provide an artificial physiological color change response to a user on the basis of one or more user-specific parameter, wherein the visualized virtual agent is configured to acquire user-specific data for at least one user-specific parameter using at least one sensor, the one or more user-specific parameter comprising activity data of the user and/or physio-psychological data of the user, and wherein the artificial physiological color change response is provided in response to monitored changes of the acquired user-specific data for the at least one user-specific parameter of the activity data of the user and/or the physio-psychological data of the user, the artificial physiological color change response comprising at least in part a color change of the visualized virtual agent.

Abstract: An optical sensor has a body including a transparent interface wall having an outer surface in contact with a liquid, to define therewith a reflection interface. An optical module is coupled at an inner surface of the interface wall, to detect a characteristic of the liquid substance via light reflection. The optical module includes a light emitter and a light receiver facing respective inclined surfaces of the interface wall. The optical module also includes a supporting structure which is elastically flexible, to enable the light emitter and the light receiver of the optical module to vary a relative position thereof and with respect to the inclined surfaces of the interface wall, when the supporting structure is secured to the inner surface of the interface wall.

Abstract: An optical sensor device (1) for a fluid substance (LS) comprises a device body (2) having a detection portion (14), associated to which is a sensitive optical part that comprises at least one of an emitter (20) and a receiver (21) of an optical radiation (Re, Rr). The detection portion (14) is made of a material transparent to the optical radiation (Re, Rr) and has an inner surface (23a, 23b) and an outer surface (15), the outer surface (15) being designed to be in contact with the fluid substance (LS) and the inner surface (23a, 23b) being designed to be isolated from the fluid substance. The at least one of the emitter (20) and the receiver (21) of the sensitive optical part is optically coupled to the inner surface (23a, 23b) of the detection portion (14), in such a way that the optical radiation (Re, Rr) is at least in part propagated through the detection portion (14), in particular with an angle and/or an intensity that is variable as a function of a characteristic of the fluid substance.

Abstract: An optical sensor device for detection of a characteristic of a liquid substance comprises a device body having an inner surface and an outer surface, one portion of the outer surface of the device body being designed to be in contact with the liquid substance, and the inner surface of the device body being designed to be isolated from the liquid substance. Associated to the device body is a detection arrangement, which comprises an emitter and a receiver of a given optical radiation. A first portion of the device body is made of a material designed for propagation of the given optical radiation, the emitter and the receiver being optically coupled to the inner surface of the device body in the first portion.

Abstract: A sensor device for a container of a liquid substance comprises a body with a housing portion having a closing structure, the body having an inner surface and an outer surface. The housing portion is pre-arranged for assembly on the container, in such a way that a portion of the outer surface of the body faces the inside of the container to be in contact with the liquid substance, and the inner surface of the body is isolated from the inside of the container. Associated to the body is a first arrangement for detection of the level of the substance. Associated to the body of the device is a second arrangement for detection of a characteristic of the liquid substance, which comprises an emitter and a receiver of a given optical radiation. A first portion of the body of the device is made of a material designed for propagation of the given optical radiation, the emitter and the receiver being optically coupled to the inner surface of the body at the first portion.

Abstract: A sensor device for a container of a liquid substance comprises a body with a housing portion having a closing structure, the body having an inner surface and an outer surface. The housing portion is pre-arranged for assembly on the container, in such a way that a portion of the outer surface of the body faces the inside of the container to be in contact with the liquid substance, and the inner surface of the body is isolated from the inside of the container. Associated to the body is a first arrangement for detection of the level of the substance. Associated to the body of the device is a second arrangement for detection of a characteristic of the liquid substance, which comprises an emitter and a receiver of a given optical radiation. A first portion of the body of the device is made of a material designed for propagation of the given optical radiation, the emitter and the receiver being optically coupled to the inner surface of the body at the first portion.

Abstract: A motor wheel assembly for a motor vehicle comprises a radial flux brushless electric motor having a plurality of stator magnets arranged along a circumferential path; a wheel; first connecting means to connect motor to wheel in a torque transfer manner and second connecting means suitable for connecting motor to the motor vehicle. The motor wheel assembly defines a seat interrupting the sequence of stator magnets along the circumferential path and is suitable for housing a caliper of a braking system of the motor vehicle.

Abstract: The present invention is directed to the use of the peptide compound D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.

Abstract: The present invention is directed to the use of the peptide compound Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilizate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.

Abstract: The present invention is directed to the use of the peptide compound Ac-Arg-Phe-Met-Trp-Met-Arg-NH2 as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Ac-Arg-Phe-Met-Trp-Met-Arg-NH2 optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.

Abstract: The present invention is directed to the use of the peptide compound Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.

Abstract: The present invention is directed to the use of the peptide compound Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquide buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.

Abstract: A motor wheel assembly for a motor vehicle comprises a radial flux brushless electric motor having a plurality of stator magnets arranged along a circumferential path; a wheel; first connecting means to connect motor to wheel in a torque transfer manner and second connecting means suitable for connecting motor to the motor vehicle. The motor wheel assembly defines a seat interrupting the sequence of stator magnets along the circumferential path and is suitable for housing a caliper of a braking system of the motor vehicle.

Abstract: A suspension system for a wheeled vehicle is provided, the suspension system being adapted to support at least one wheel of the vehicle and comprising at least one shock absorbing device adapted to be activated as a result of the motion of the at least one wheel in a substantially vertical direction, the suspension system further comprising electrical power generating means in fluid connection with the at least one shock absorbing device so that the activation of said at least one shock absorbing device results in electrical power being generated. Furthermore, the suspension system comprises means for absorbing at least partially the electrical power generated, the absorption of electrical power resulting in the stiffness of said at least one shock absorbing device being varied as a function of the electrical power absorbed.

Abstract: The present invention is directed to the use of the peptide compound D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.

Abstract: The present invention is directed to the use of the peptide compound Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp-OH optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.

Abstract: The present invention is directed to the use of the peptide compound His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-OH optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.